The BioPharma Supply Chain in Recessionary Times: Economy and Job Outlook
Despite the current global economic uncertainty, temperature controlled professionals in the life sciences are optimistic about job prospects, and growth is predicted for 2013 and beyond.
While R&D pipelines shrink and many pharmaceutical companies are looking to restructure their drug development operations and do more with less.
Cold Chain IQ’s 2012 "Economy and Job Outlook Survey – Cold Chain Pharma in Recessionary Times" survey research shows that majority of manufacturers of life science products and temperature control solution/service providers plan to invest in new technologies to tackle their supply chain challenges and improve the efficiency of their operations.
- 84% of manufacturers think their company is better prepared to cope if a recession hits in 2013
- Over half of manufacturers of life science products (53%) are looking to expand into Asia in the next 12 – 18 months
- 46% of life science manufacturers think their company should be investing in packaging in the next 12 months to increase profitability
To find out more download The BioPharma Supply Chain in Recessionary Times: Economy and Job Outlook now!
|Have Your Say|
Rate this feature and give us your feedback in the comments section below
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
Or if you're already a Cold Chain IQ member, sign in below to download.